New hope for Tough-to-Treat gynecologic cancers

NCT ID NCT03564340

Recruiting now Disease control Sponsor: Regeneron Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study is testing a new drug called ubamatamab, given alone or with another drug (cemiplimab), for people with recurrent ovarian, fallopian tube, peritoneal, or endometrial cancers. The main goals are to find a safe and effective dose and to see if the treatment can shrink tumors. It is for patients whose cancer has come back after prior treatments and who have limited standard options.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Asan Medical Center, Univ. of Ulsan
RECRUITING

Seoul, 05505, South Korea
Centre Antoine Lacassagne
RECRUITING

Nice, Provence Alpes Cote dAzur, 06189, France
Centre Francois Baclesse (CFB)
RECRUITING

Caen, Normandy, 14076, France
Centre Georges Francois Leclerc
RECRUITING

Dijon, Bourgogne-Franche-Comté, 21000, France
Clinica Universidad Navarra (CUN) Madrid
RECRUITING

Madrid, 28027, Spain
Clinica Universidad de Navarra
RECRUITING

Pamplona, Navarre, 31008, Spain
Columbia University Medical Center
RECRUITING

New York, New York, 10032, United States
Dana Farber / Harvard Cancer Center
RECRUITING

Boston, Massachusetts, 02215, United States
Erasmus MC
RECRUITING

Rotterdam, South Holland, 3000 DR, Netherlands
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
RECRUITING

Rome, Lazio, 00168, Italy
Fundacion Jimenez Diaz
RECRUITING

Madrid, 28040, Spain
Grand Hopital de Charleroi
RECRUITING

Charleroi, Hainaut, 6000, Belgium
Guys Hospital
RECRUITING

London, SE1 9RT, United Kingdom
Hopital Lyon Sud
RECRUITING

Pierre-Bénite, Auvergne-Rhône, 69310, France
Hospital Clinico Universitatio Santiago de Compostela
RECRUITING

Santiago de Compostela, 15706, Spain
Hospital Universitari Vall d'Hebron
RECRUITING

Barcelona, 08035, Spain
Hospital Universitario San Carlos
RECRUITING

Madrid, 28040, Spain
Imperial College Healthcare NHS Trust
RECRUITING

London, W12 0HS, United Kingdom
Institut Bergonie
RECRUITING

Bordeaux, Nouvelle-Aquitaine, 33076, France
Institut Catala d'Oncologia
RECRUITING

Barcelona, 8908, Spain
Institut Catala dOncologia Badalona
RECRUITING

Badalona, 08916, Spain
Institut Gustave Roussy
RECRUITING

Villejuif, Île-de-France Region, 94800, France
Instituto Nazionale Tumori- Fondazione Pascale
RECRUITING

Naples, 80131, Italy
Istituto Europeo di Oncologia
RECRUITING

Milan, 20141, Italy
Korea University Guro Hospital
RECRUITING

Seoul, 08307, South Korea
Massachusetts General Hospital
RECRUITING

Boston, Massachusetts, 02114, United States
Mayo Clinic - Rochester
RECRUITING

Rochester, Minnesota, 55901, United States
Memorial Sloan Kettering Cancer Center
RECRUITING

New York, New York, 10065, United States
Peter MacCallum Cancer Center
COMPLETED

Melbourne, 3000, Australia
Prince of Wales Hospital
COMPLETED

Randwick, New South Wales, 2031, Australia
Radboudumc
RECRUITING

Nijmegen, Gelderland, 6500HB, Netherlands
Rambam Health Care Campus
RECRUITING

Haifa, 3109601, Israel
Roswell Park Cancer Institute
WITHDRAWN

Buffalo, New York, 14263, United States
Royal Marsden Hospital - Sutton
WITHDRAWN

Sutton, Surrey, SM2 5PT, United Kingdom
Samsung Medical Center
RECRUITING

Seoul, 06351, South Korea
Sarah Cannon Research Institute
RECRUITING

Nashville, Tennessee, 37203, United States
Seoul National University Hospital
RECRUITING

Seoul, 3080, South Korea
Sharet Institute of Oncology
RECRUITING

Jerusalem, 9112001, Israel
Sheba Medical Center
RECRUITING

Tel Litwinsky, 5265601, Israel
Stephenson Cancer Center
RECRUITING

Oklahoma City, Oklahoma, 73104, United States
The Christie NHS Foundation Trust
RECRUITING

Manchester, M20 4BX, United Kingdom
The Ohio State University Wexner Medical Center James Comprehensive Cancer Center
RECRUITING

Hilliard, Ohio, 43026, United States
The Royal Marsden NHS Foundation Trust
RECRUITING

Sutton, Surrey, SM2 5PT, United Kingdom
UZLeuven
RECRUITING

Leuven, Vlaams-Brabant, 3000, Belgium
Universitair Ziekenhuis Antwerpen
RECRUITING

Edegem, Antwerp, 2650, Belgium
University College London Hospitals
RECRUITING

London, NW1 2PG, United Kingdom
University Medical Center Groningen
RECRUITING

Groningen, 9713 GZ, Netherlands
University of Alabama_6th Ave
RECRUITING

Birmingham, Alabama, 35294, United States
University of Oxford
RECRUITING

Oxford, Oxfordshire, OX1 2JD, United Kingdom
Virginia Commonwealth University
RECRUITING

Richmond, Virginia, 23219, United States
Yonsei University Health System
RECRUITING

Seoul, 03722, South Korea

Conditions

Explore the condition pages connected to this study.

ENDOMETRIAL CANCER LOW-GRADE SEROUS OVARIAN CANCER RECURRENT ENDOMETRIAL CANCER RECURRENT FALLOPIAN TUBE CANCER RECURRENT OVARIAN CANCER RECURRENT PRIMARY PERITONEAL CANCER